by Timileyin Ajuwon | Nov 26, 2024 | MS TODAY, Research
We are excited to share the latest research insights from the Buffalo Neuroimaging Analysis Center (BNAC) presented at the ECTRIMS 2024 meeting in Copenhagen, Denmark. This year, BNAC showcased six compelling abstracts highlighting advancements in understanding...
by Timileyin Ajuwon | Aug 28, 2024 | MS TODAY, MS Treatments, Research
From the moment someone is diagnosed with multiple sclerosis, a maze of barriers awaits. But in York Region, such people aren’t alone. Other residents who also have MS, an auto-immune disease affecting the central nervous system, volunteer to help them buy...
by Timileyin Ajuwon | Dec 25, 2023 | MS Medications, MS Meds and your skin conditions, MS TODAY, MS Treatments, VISION
Treatment with Mavenclad (cladribine) over two years significantly improved physical and mental health aspects of quality of life in people with highly active relapsing multiple sclerosis, according to a final analysis of data from a Phase 4 study. Mavenclad is an...
by Peter | May 5, 2022 | MS TODAY, VISION
Multiple Sclerosis News Today | Symptoms, Diagnosis, Treatments May 5, 2022 Newsby Marisa Wexler MSStudy Finds New Molecules Targeted by the Immune System Researchers have identified four new brain proteins that are targeted by inflammatory T-cells in...